Starting Mounjaro at the lowest recommended dose (2.5 mg once weekly) and following the gradual titration schedule can help minimise these effects
There have been no clinical studies specifically evaluating the safety of topical GHK-Cu during pregnancy or breastfeeding
(PubMed) DeLong GR, Leslie PW, Wang SH, et al
JAMA Netw Open 7(8):e2423385 Zhou J, Huang W, Xie Y, Shen H, Liu M, Wu X (2025) Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database
Patient stories and the human side Clinical practice is full of examples that illustrate both the promise and the complexity of these tools
Among patients who had started treatment for obesity, 55 percent gained weight during the year after stopping